Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-23-001482
Filing Date
2023-04-21
Accepted
2023-04-21 07:00:14
Documents
1
Period of Report
2023-04-21

Document Format Files

Seq Description Document Type Size
1 6-K zk2329557.htm 6-K 17413
  Complete submission text file 0001178913-23-001482.txt   18358
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 23834485
SIC: 2834 Pharmaceutical Preparations